Ajanta Pharma launches Levetiracetam Immediate-Release Tablets

26 Mar 2016 Evaluate

Ajanta Pharma has launched Levetiracetam Immediate-Release Tablets (250mg, 500mg, 750mg, 1000mg) in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc. Levetiracetam cures epileptic neurological disorder like numbness, blindness, paralysis or fits and is a bioequivalent generic version of Keppra.

The company’s launch of Levetiracetam Tablets is part of an ever-growing portfolio of products that Ajanta has developed for the U.S. market. To date, the United States Food & Drug Administration (FDA) has granted Ajanta Pharma's eight ANDAs final approvals and two tentative approvals. An additional 16 ANDAs are pending approval from the FDA.

Ajanta Pharma is a fully-integrated pharmaceutical company with global headquarters in Mumbai, India. Over 6,000 employees are engaged in developing, manufacturing and marketing of quality finished dosages across 35 countries.

Ajanta Pharma Share Price

2757.35 -12.90 (-0.47%)
01-Jan-2026 09:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1710.70
Dr. Reddys Lab 1253.15
Cipla 1500.60
Zydus Lifesciences 910.00
Lupin 2095.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×